Manufacture of pharmaceutical preparations
AGILERA PHARMA AS
Revenue 2024
NOK 357.6m
Operating profit
NOK −29.0m
Equity
NOK 15.0m
Incorporated
2021
Employees
137
Share capital
NOK 4.5m
Roles
Daglig lederErik Flatmark
Revisor
Styrets lederNils Morten Huseby
StyremedlemThomas Møen Halvorsen
StyremedlemElisabeth Strålberg
StyremedlemAnne Elisabeth Laingen
VaramedlemInger Lill Skuland
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| PHARMALOGIC NORWAY AS | 51.0% | 15300.000000 | 2025 |
| IFE HOLDING AS | 49.0% | 14700.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.